vs
Side-by-side financial comparison of ASTROTECH Corp (ASTC) and Tivic Health Systems, Inc. (TIVC). Click either name above to swap in a different company.
ASTROTECH Corp is the larger business by last-quarter revenue ($148.0K vs $146.0K, roughly 1.0× Tivic Health Systems, Inc.). Tivic Health Systems, Inc. runs the higher net margin — -1778.1% vs -2653.4%, a 875.3% gap on every dollar of revenue. On growth, Tivic Health Systems, Inc. posted the faster year-over-year revenue change (15.9% vs -43.3%). Tivic Health Systems, Inc. produced more free cash flow last quarter ($-2.0M vs $-4.0M). Over the past eight quarters, Tivic Health Systems, Inc.'s revenue compounded faster (-36.0% CAGR vs -40.2%).
Astrotech Corporation, formerly Spacehab Inc., is a technology incubator headquartered in Austin, Texas. Astrotech uses technology sourced internally and from research institutions, government laboratories, and universities to fund, manage and sell start-up companies. Astrotech Corporation's subsidiaries provide commercial products and services to NASA, the U.S. Department of Defense, national space agencies, and global commercial customers.
Tivic Health Systems, Inc. is a medical technology firm that develops and sells non-invasive, drug-free bioelectronic devices for chronic health condition management. Its flagship product relieves sinus pain and congestion, serving US consumer healthcare markets, with ongoing R&D for new devices targeting other common ailments.
ASTC vs TIVC — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.0K | $146.0K |
| Net Profit | $-3.9M | $-2.6M |
| Gross Margin | 5.4% | -99.3% |
| Operating Margin | -2635.8% | -1700.7% |
| Net Margin | -2653.4% | -1778.1% |
| Revenue YoY | -43.3% | 15.9% |
| Net Profit YoY | 2.0% | -81.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.0K | — | ||
| Q3 25 | $297.0K | $146.0K | ||
| Q2 25 | $220.0K | $86.0K | ||
| Q1 25 | $534.0K | $70.0K | ||
| Q4 24 | $261.0K | $180.0K | ||
| Q3 24 | — | $126.0K | ||
| Q2 24 | — | $140.0K | ||
| Q1 24 | — | $334.0K |
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $-3.5M | $-2.6M | ||
| Q2 25 | $-2.9M | $-1.9M | ||
| Q1 25 | $-3.6M | $-1.5M | ||
| Q4 24 | $-4.0M | $-1.5M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.3M | ||
| Q1 24 | — | $-1.5M |
| Q4 25 | 5.4% | — | ||
| Q3 25 | 63.3% | -99.3% | ||
| Q2 25 | 33.6% | 62.8% | ||
| Q1 25 | 44.4% | 71.4% | ||
| Q4 24 | 59.4% | -132.8% | ||
| Q3 24 | — | 34.9% | ||
| Q2 24 | — | 21.4% | ||
| Q1 24 | — | 50.0% |
| Q4 25 | -2635.8% | — | ||
| Q3 25 | -1190.6% | -1700.7% | ||
| Q2 25 | -1326.4% | -2248.8% | ||
| Q1 25 | -724.2% | -2151.4% | ||
| Q4 24 | -1655.6% | -165.6% | ||
| Q3 24 | — | -1135.7% | ||
| Q2 24 | — | -904.3% | ||
| Q1 24 | — | -443.4% |
| Q4 25 | -2653.4% | — | ||
| Q3 25 | -1166.7% | -1778.1% | ||
| Q2 25 | -1331.8% | -2245.3% | ||
| Q1 25 | -680.3% | -2145.7% | ||
| Q4 24 | -1536.0% | -820.6% | ||
| Q3 24 | — | -1135.7% | ||
| Q2 24 | — | -904.3% | ||
| Q1 24 | — | -443.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-2.19 | ||
| Q1 25 | — | $-2.52 | ||
| Q4 24 | — | $3.07 | ||
| Q3 24 | — | $-0.23 | ||
| Q2 24 | — | $-5.37 | ||
| Q1 24 | — | $-17.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.0M | $3.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.5M | $3.4M |
| Total Assets | $19.7M | $6.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.0M | — | ||
| Q3 25 | $11.3M | $3.5M | ||
| Q2 25 | $15.1M | $1.2M | ||
| Q1 25 | $18.1M | $669.0K | ||
| Q4 24 | $21.5M | $2.0M | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $3.7M | ||
| Q1 24 | — | $1.7M |
| Q4 25 | $15.5M | — | ||
| Q3 25 | $19.1M | $3.4M | ||
| Q2 25 | $22.1M | $3.3M | ||
| Q1 25 | $24.8M | $3.0M | ||
| Q4 24 | $28.1M | $2.5M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $2.2M |
| Q4 25 | $19.7M | — | ||
| Q3 25 | $23.2M | $6.2M | ||
| Q2 25 | $27.0M | $4.5M | ||
| Q1 25 | $27.5M | $3.8M | ||
| Q4 24 | $31.0M | $2.8M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | — | $4.8M | ||
| Q1 24 | — | $3.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | $-2.0M |
| Free Cash FlowOCF − Capex | $-4.0M | $-2.0M |
| FCF MarginFCF / Revenue | -2671.6% | -1374.0% |
| Capex IntensityCapex / Revenue | 277.7% | 6.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-14.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-3.9M | $-2.0M | ||
| Q2 25 | $-2.4M | $-1.8M | ||
| Q1 25 | $-3.9M | $-889.0K | ||
| Q4 24 | $-3.0M | $-1.4M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.3M | ||
| Q1 24 | — | $-1.7M |
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $-4.4M | $-2.0M | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q4 24 | $-3.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -2671.6% | — | ||
| Q3 25 | -1476.1% | -1374.0% | ||
| Q2 25 | -1231.4% | — | ||
| Q1 25 | -728.1% | — | ||
| Q4 24 | -1288.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 277.7% | — | ||
| Q3 25 | 150.8% | 6.8% | ||
| Q2 25 | 158.2% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 122.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
